AngioDynamics
ANGO
179 hedge funds and large institutions have $839M invested in AngioDynamics in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 71 increasing their positions, 65 reducing their positions, and 14 closing their positions.
43% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 14
12% more capital invested
Capital invested by funds: $747M → $839M (+$91.8M)
3% more funds holding
Funds holding: 174 → 179 (+5)
9% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 65
6% more call options, than puts
Call options by funds: $506K | Put options by funds: $478K
1.17% less ownership
Funds ownership: 99.96% → 98.79% (-1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$16.2M |
| 2 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
+$4.36M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.21M |
| 4 |
Goldman Sachs
New York
|
+$1.58M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$899K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$6.79M |
| 2 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$3.37M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.19M |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$2.85M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.08M |
ANGO Hedge Fund Activity: Q1 2019 in Review
179 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2019, worth a combined $839M — up 12% from $747M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new ANGO positions and 14 closed out — a net gain of 6 holders — while 71 added to existing stakes and 65 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $16.2M. The largest seller was Segall Bryant & Hamill, cutting an estimated $6.79M.
- 179 institutional investors held AngioDynamics (ANGO) as of Q1 2019, up from 174 in Q4 2018.
- Funds reported $839M of AngioDynamics stock for Q1 2019, up 12% quarter-over-quarter.
- 20 funds opened new AngioDynamics positions in Q1 2019 and 14 closed out, a net change of +6 holders.
- The largest AngioDynamics buyer in Q1 2019 was Victory Capital Management, an estimated $16.2M added.
- The largest AngioDynamics seller in Q1 2019 was Segall Bryant & Hamill, an estimated $6.79M sold.
Based on aggregated 13F filings for Q1 2019.